Recently, DNA methylation and histone acetylation status of 5′ sequences of CD7 and ELA2, genes associated with CML clinical outcome, in leukaemic cell lines and primitive leukaemic cells from chronic phase CML patients have been reported to contribute to the variable expression of these two genes (6). Here, ELANE is linked to chronic myelogenous leukemia, BCR-ABL1 positive.